Metraipolis › archive › dc_cbf71a1ef4ce

Alpelisib in PIK3CA-Related Overgrowth Spectrum (PROS): A Systematic Review of Real-World Evidence in over 100 Patients — Europe PMC PMID:42121892

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42121892
DOI
10.3390/cells15090788
License (as archived)
solo-consultazione
Archived
2026-11-03T04:13:54.661Z
SHA-256 of the archived text
af9c6685a2e8d6fb24203479f1c00bedb623166e6043f463cf6dda8ef09fd8ab
Stable URL of this page
https://metraipolis.com/documento/dc_cbf71a1ef4ce

How to cite

Alpelisib in PIK3CA-Related Overgrowth Spectrum (PROS): A Systematic Review of Real-World Evidence in over 100 Patients — Europe PMC PMID:42121892 — Europe PMC (en), https://europepmc.org/article/MED/42121892 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cbf71a1ef4ce (Metraipolis archive dc_cbf71a1ef4ce, sha256 af9c6685a2e8d6fb24203479f1c00bedb623166e6043f463cf6dda8ef09fd8ab)
BibTeX
@misc{dccbf71a1ef4ce,
  title = {Alpelisib in PIK3CA-Related Overgrowth Spectrum (PROS): A Systematic Review of Real-World Evidence in over 100 Patients — Europe PMC PMID:42121892},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42121892},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cbf71a1ef4ce; sha256 af9c6685a2e8d6fb24203479f1c00bedb623166e6043f463cf6dda8ef09fd8ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42121892. Agents can read the archived copy with the MCP tool read_document.